CAMP4 Therapeutics Reports Collaboration With Biogen For Addressing Neurodegenerative, Neurological Disease; Co. To Receive $15M Upfront Payment, Development, Milestone Payments Of Up To $96M Plus Future Royalties For Up To $173M
Benzinga Newsdesk